newsfilter
← Latest News
Business Wire·

DiaMedica Therapeutics Elects Two Industry Veterans to Its Board of Directors

Amy Burroughs and Dr. Charles Semba Bring Extensive and Complementary Experience in Building Specialty Therapeutics Companies DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments